P35869 (AHR_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 139.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Aryl hydrocarbon receptor Short name=Ah receptor Short name=AhR Alternative name(s): Class E basic helix-loop-helix protein 76 Short name=bHLHe76 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 848 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Ligand-activated transcriptional activator. Binds to the XRE promoter region of genes it activates. Activates the expression of multiple phase I and II xenobiotic chemical metabolizing enzyme genes (such as the CYP1A1 gene). Mediates biochemical and toxic effects of halogenated aromatic hydrocarbons. Involved in cell-cycle regulation. Likely to play an important role in the development and maturation of many tissues. Ref.10 Ref.11 |
| Subunit structure | Binds MYBBP1A By similarity. Efficient DNA binding requires dimerization with another bHLH protein. In the nucleus, heterodimer of AHR and ARNT. Interacts with coactivators including SRC-1, RIP140 and NOCA7, and with the corepressor SMRT. Interacts with NEDD8 and IVNS1ABP. Ref.11 Ref.14 Ref.15 |
| Subcellular location | Cytoplasm. Nucleus. Note: Initially cytoplasmic; upon binding with ligand and interaction with a HSP90, it translocates to the nucleus. |
| Tissue specificity | Expressed in all tissues tested including blood, brain, heart, kidney, liver, lung, pancreas and skeletal muscle. Ref.2 Ref.9 |
| Induction | Induced or repressed by TGFB1 and dioxin in a cell-type specific fashion. Repressed by cAMP, retinoic acid, and 12-O-tetradecanoyl phorbol-13 acetate (TPA). Ref.12 |
| Sequence similarities | Contains 1 bHLH (basic helix-loop-helix) domain. Contains 1 PAC (PAS-associated C-terminal) domain. Contains 2 PAS (PER-ARNT-SIM) domains. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ARNT | P27540 | 5 | EBI-80780,EBI-80809 | |
| EBNA3 | P12977 | 5 | EBI-80780,EBI-993115 | From a different organism. |
| NCOA7 | Q8NI08 | 2 | EBI-80780,EBI-80799 | |
| NCOR2 | Q9Y618 | 2 | EBI-80780,EBI-80830 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Propeptide | 1 – 10 | 10 | By similarity | PRO_0000013450 | |||||
| Chain | 11 – 848 | 838 | Aryl hydrocarbon receptor | PRO_0000013451 | |||||
Regions | |||||||||
| Domain | 27 – 80 | 54 | bHLH | ||||||
| Domain | 111 – 181 | 71 | PAS 1 | ||||||
| Domain | 275 – 342 | 68 | PAS 2 | ||||||
| Domain | 348 – 386 | 39 | PAC | ||||||
| Compositional bias | 600 – 640 | 41 | Gln-rich | ||||||
Natural variations | |||||||||
| Natural variant | 517 | 1 | P → S. Ref.20 | VAR_015516 | |||||
| Natural variant | 554 | 1 | R → K. Ref.17 Ref.18 Ref.19 Corresponds to variant rs2066853 [ dbSNP | Ensembl ]. | VAR_009281 | |||||
| Natural variant | 570 | 1 | V → I. Ref.18 Ref.20 Corresponds to variant rs4986826 [ dbSNP | Ensembl ]. | VAR_009282 | |||||
| Natural variant | 786 | 1 | M → V. Ref.19 | VAR_015517 | |||||
Experimental info | |||||||||
| Mutagenesis | 381 | 1 | V → A: Increases specific ligand binding. Ref.10 | ||||||
| Mutagenesis | 381 | 1 | V → D: Abolishes specific ligand binding. Ref.10 | ||||||
| Mutagenesis | 381 | 1 | V → L or G: No effect on specific ligand binding. Ref.10 | ||||||
| Sequence conflict | 191 | 1 | E → EG in AAA92082. Ref.8 | ||||||
| Sequence conflict | 340 – 341 | 2 | MI → SD Ref.9 | ||||||
| Sequence conflict | 807 – 848 | 42 | LNETY…SSGFL → FK in BAA03857. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human Ah receptor cDNA: analysis for highly conserved sequences." Itoh S., Kamataki T. Nucleic Acids Res. 21:3578-3578(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [2] | "Cloning and expression of a human Ah receptor cDNA." Dolwick K.M., Schmidt J.V., Carver L.A., Swanson H.I., Bradfield C.A. Mol. Pharmacol. 44:911-917(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY. |
| [3] | "Human arylhydrocarbon receptor: functional expression and chromosomal assignment to 7p21." Ema M., Matsushita N., Sogawa K., Ariyama T., Inazawa J., Nemoto T., Ota M., Oshimura M., Fujii-Kuriyama Y. J. Biochem. 116:845-851(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [4] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Placenta. |
| [8] | "Complete structural characterisation of the human aryl hydrocarbon receptor gene." Bennett P., Ramsden D.B., Williams A.C. Clin. Mol. Pathol. 49:M12-M16(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 5-235; 388-461 AND 764-848. |
| [9] | "Interindividual difference in expression of human Ah receptor and related P450 genes." Hayashi S., Watanabe J., Nakachi K., Eguchi H., Gotoh O., Kawajiri K. Carcinogenesis 15:801-806(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 236-341, TISSUE SPECIFICITY. |
| [10] | "Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors." Ema M., Ohe N., Suzuki M., Mimura J., Sogawa K., Ikawa S., Fujii-Kuriyama Y. J. Biol. Chem. 269:27337-27343(1994) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF VAL-381. |
| [11] | "Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex." Nguyen T.A., Hoivik D., Lee J.-E., Safe S. Arch. Biochem. Biophys. 367:250-257(1999) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBUNIT. |
| [12] | "Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1)." Wolff S., Harper P.A., Wong J.M.Y., Mostert V., Wang Y., Abel J. Mol. Pharmacol. 59:716-724(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [13] | "Role of the aryl hydrocarbon receptor in cell cycle regulation." Puga A., Xia Y., Elferink C. Chem. Biol. Interact. 141:117-130(2002) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON ROLE IN CELL CYCLE. |
| [14] | "Interaction with Nedd8, a ubiquitin-like protein, enhances the transcriptional activity of the aryl hydrocarbon receptor." Antenos M., Casper R.F., Brown T.J. J. Biol. Chem. 277:44028-44034(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NEDD8. |
| [15] | "The aryl hydrocarbon receptor signaling pathway is modified through interactions with a Kelch protein." Dunham E.E., Stevens E.A., Glover E., Bradfield C.A. Mol. Pharmacol. 70:8-15(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH IVNS1ABP. |
| [16] | "Polymorphisms in the human AH receptor." Harper P.A., Wong J.M.Y., Lam M.S.M., Okey A.B. Chem. Biol. Interact. 141:161-187(2002) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON VARIANTS. |
| [17] | "Polymorphisms of human Ah receptor gene are not involved in lung cancer." Kawajiri K., Watanabe J., Eguchi H., Nakachi K., Kiyohara C., Hayashi S. Pharmacogenetics 5:151-158(1995) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT LYS-554. |
| [18] | "Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms." Smart J., Daly A.K. Pharmacogenetics 10:11-24(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LYS-554 AND ILE-570. |
| [19] | "Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer." Cauchi S., Stucker I., Solas C., Laurent-Puig P., Cenee S., Hemon D., Jacquet M., Kremers P., Beaune P., Massaad-Massade L. Carcinogenesis 22:1819-1824(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LYS-554 AND VAL-786. |
| [20] | "Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction." Wong J.M.Y., Okey A.B., Harper P.A. Biochem. Biophys. Res. Commun. 288:990-996(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS SER-517 AND ILE-570. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | D16354 mRNA. Translation: BAA03857.1. L19872 mRNA. Translation: AAA16210.1. AC003075 Genomic DNA. No translation available. CH236948 Genomic DNA. Translation: EAL24281.1. CH471073 Genomic DNA. Translation: EAW93686.1. BC069390 mRNA. Translation: AAH69390.1. BC070080 mRNA. Translation: AAH70080.1. U28063 U28062 Genomic DNA. Translation: AAA92082.1.U28064 Genomic DNA. Translation: AAA92083.1. U28066, U28065 Genomic DNA. Translation: AAA92084.1. D38044 Genomic DNA. Translation: BAA07235.1. |
| IPI | IPI00021008. |
| PIR | S59514. |
| RefSeq | NP_001612.1. NM_001621.4. |
| UniGene | Hs.171189. |
3D structure databases | |
| DisProt | DP00381. |
| ProteinModelPortal | P35869. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-946N. |
| IntAct | P35869. 11 interactions. |
| STRING | 9606.ENSP00000242057. |
PTM databases | |
| PhosphoSite | P35869. |
Polymorphism databases | |
| DMDM | 3041653. |
Proteomic databases | |
| PaxDb | P35869. |
| PRIDE | P35869. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000242057; ENSP00000242057; ENSG00000106546. ENST00000463496; ENSP00000436466; ENSG00000106546. |
| GeneID | 196. |
| KEGG | hsa:196. |
| UCSC | uc011jxz.1. human. |
Organism-specific databases | |
| CTD | 196. |
| GeneCards | GC07P017304. |
| HGNC | HGNC:348. AHR. |
| HPA | CAB005072. HPA029722. HPA029723. |
| MIM | 600253. gene. |
| neXtProt | NX_P35869. |
| PharmGKB | PA24641. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG253623. |
| HOGENOM | HOG000252935. |
| HOVERGEN | HBG007313. |
| InParanoid | P35869. |
| KO | K09093. |
| OMA | QQLCQKM. |
| OrthoDB | EOG42BX7X. |
| PhylomeDB | P35869. |
Gene expression databases | |
| Bgee | P35869. |
| CleanEx | HS_AHR. |
| Genevestigator | P35869. |
Family and domain databases | |
| Gene3D | 4.10.280.10. 1 hit. |
| InterPro | IPR011598. bHLH_dom. IPR001610. PAC. IPR000014. PAS. IPR013767. PAS_fold. IPR013655. PAS_fold_3. [Graphical view] |
| Pfam | PF00010. HLH. 1 hit. PF00989. PAS. 1 hit. PF08447. PAS_3. 1 hit. [Graphical view] |
| SMART | SM00353. HLH. 1 hit. SM00086. PAC. 1 hit. SM00091. PAS. 2 hits. [Graphical view] |
| SUPFAM | SSF47459. HLH_basic. 1 hit. |
| PROSITE | PS50888. BHLH. 1 hit. PS50113. PAC. False negative. PS50112. PAS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | P35869. |
| ChEMBL | CHEMBL3201. |
| ChiTaRS | AHR. human. |
| GenomeRNAi | 196. |
| NextBio | 786. |
| SOURCE | Search... |
Entry information
| Entry name | AHR_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P35869 Secondary accession number(s): A4D130 Q13804 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
